mount an anti-H-Y cytotoxic response (1) (2) (3) (4) (5) (6) . In brief, female mice were primed with male spleen cells intraperitoneally, or with a male skin graft, and spleen cells from these mice were then restimulated in vitro in mixed lymphocyte culture with the male spleen cells from the strain used for priming. Priming with spleen cells or by skin grafting has always given identical results and, in fact, there is evidence that in skin grafting, the passenger leukocytes are responsible for the priming of the recipient (15) . In Tables II-IV , the capacity of cytotoxic cell production is indicated as positive or negative. The criteria for a positive result are set out in the accompanying paper (6) and are shown in detail in that paper. Female mice of various inbred strains were first grafted with syngeneic male skin. Early rejection was associated with the H-2 b haplotype: in B10 and in the recombinant strains having a part of the H-2 b haplotype (B10.A(4R), B10.A(5R) and HTI), the median survival time of the graft varied from 21 to 65 days (Table  II) , but the differences between these strains were not statistically significant. In all the other strains, only one or two grafts were rejected in 100 days (in every group, P < 0.01 when compared to B10.A(5R) group). We used B10.HTG mice instead of HTG, and the absence of rejection in these mice confirms the findings of Gasser and Shreffler (11) that the male skin graft rejection by HTG females is caused by genes outside H-2. Of those mouse strains able to reject 50% of skin grafts in less than 65 days, only B10 mice were able to mount a secondary cytotoxic reaction against syngeneic male cells in vitro. Of the strains unable to reject grafts, only C3H.OH was able to produce cytotoxic cells.
In studies on the dominance of the genes causing rapid skin graft rejection (Table III) , it was found that (B10 x BALB/c)F1 females rejected male skin grafts from either parental strain, and this rejection was accompanied by the ability to mount a cytotoxic response. Similar results have been obtained for example with (B10 x CBA)F1 females (data not shown). The dominance of H-2 b gene(s) in skin graft rejection was also seen in the experiments with (HTI x B10.A(2R))F1 and (BALB/c x B10.A(5R))F1 females, but in contrast to the 
TABLE Ill

Rejection of Parental Male Skin Graft by F, Hybrid Females Derived from Matings with One Parent Carrying All or Part of the H-2 b Haplotype
A.TL 6 >100 -results with (B10 x BALB/c)F, mice, no cytotoxic response could be mounted after graftings with HTI and B10.A(5R) male skin, respectively. Concomitant absence of skin graft rejection and cytotoxic cell production was noticed in (B10 x A.TL)F1 females grafted with A.TL male skin. The grafting results with F, hybrids derived from matings of strains not involving the H-2 b haplotype and unable to reject male skin grafts were clear: the male skin grafts from either parental strain were not rejected regardless of their capacity to produce cytotoxic cells (Table IV) .
Using B10 background H-2 congenic mouse strains, some of the strain combinations using noncongenic strains shown in Tables III and IV were 
results were always concordant with those shown, and they indicate that non-H-2 genes were not involved.
Discussion The results show that the genes enabling rapid rejection of syngeneic male skin grafts by female mice are not the same as those that enable the production of H-2-restricted anti-H-Y cytotoxic cells. Thus, by using suitable recombinant mouse strains and F1 hybrids, skin graft rejection without concomitant production of anti-H-Y cytotoxic cell formation has been obtained and vice versa. Table V shows a summary of these results. Only mice with all or part of the H-2 b haplotype could reject grafts. The common part of the H-2 b haploytpe in mice able to reject male skin grafts is.the IB region. Regardless of the presence ofIB ~ in all of these strains, the variations in graft survival time indicate that other parts of the H-2 may have a regulatory effect. These results are in agreement with those of Bailey (12) , but Bailey's orthotopic tailskin grafting method is more sensitive. His graft survival times were thus much shorter than ours, and some of our nonrejector strains could be classified as slow rejectors. B10.A(SR) and HTI strains also have the IA b region which contains the Ir gene(s) for anti-H-Y cytotoxic cell production (6), but both strains lack the proper associative antigen for the induction of a cytotoxic response (we have never obtained an anti-H-Y response associated with H-2K b-or H-2Dd-region products). B10.A(4R), having IA k and IB b, are able to reject syngeneic male skin grafts due to the presence of IB b, but they are unable to produce cytotoxic cells due to the absence of IA b, regardless of the presence of appropriate associative antigens (H-2D b and H-2Kk). This confirms a different localization of those Ir genes controlling skin graft rejection and those enabling cytotoxic cell production in mice carrying the H-2 b haplotype. Both of these genes show dominant character, but the cytotoxic response needs the proper associative antigen to occur, thus, for example (B10 x BALB/c)F1 females are able to reject Tables II-IV. BALB/c male skin and to mount an H-2Kd-associated anti-H-Y cytotoxic response. The lack of dominance of genes causing rapid skin graft rejection was noticed in (B10 x A.TL)F1 females: they did not reject skin grafts from A.TL males. It is noteworthy that A.TL mice, having H-2K s and H-2D d with which H-Y antigen cannot be associated in the cytotoxic reaction (5), were not able to induce a cytotoxic response. So in this case, there is a concomitant absence of cytotoxic cell formation and skin graft rejection. This was also true of (B10 x A.TH)FI females, which did not reject male skin from A.TH (H-2K ~, H-2D d) mice (data not shown).
If the H-2 b genes causing rapid skin graft rejection were absent and the cytotoxic cells were produced by the interaction of complementary Ir genes (H2k/H-2 d, H-2k/H-2L and H-2q/H-2 s complementations), male skin grafts were not rejected. C3H.OH females grafted with syngeneic male skin were able to produce a cytotoxic response but failed to reject the graft. The possible mechanisms in cytetoxic cell formation in this strain are discussed in the accompanying paper (6) . Those F~ hybrids mentioned in Table IV were also regrafted, but second-set rejection was not observed (data not shown).
In conclusion, it seems that H-2-restricted anti-H-Y cytotoxic T cells are neither necessary nor sufficient for the rejection of syngeneic male skin grafts, and that these two phenomena are even regulated by different genes. This was a highly unexpected finding because in allograft rejection the cytotoxic T cells are of prime importance, although the actual rejection phase is probably not an autonomous T-cell function (16, 17) . So we must assume that syngeneic male skin graft rejection is mediated by a different mechanism which is not detectable in vitro using the chromium release assay, and that anti-H-Y cytotoxic T cells have no in vivo significance. One possibility is that H-2-restricted cytotoxic T cells are not directed against the correct antigen, and, in fact, there is recent evidence that there are two H-Y antigens. Melvold et al. (18) found a mutant (C57BL/6 × BALB/c)F1 male mouse lacking the H-Y antigen on the basis of skin graft testing, but the serological tests for H-Y antigen were positive. This mouse, from an X-irradiated father, had 39 chromosomes and the Y chromosome was probably absent (a part of the Y chromosome was probably translocated to an autosome). They suggested the existence of two H-Y antigens: H-Y1, responsible for male-female graft incompatibility (part of the Y chromosome coding for this antigen was missing in their mouse), and H-Y2, which is defined by conventional serological means. This could explain why strains both which do and which do not reject syngeneic male skin grafts may make an antibody response against H-Y (19), implying that anti-H-Y1 and anti-H-Y2 responses are under separate Ir gene control. If we use this hypothesis in explaining our data, we must again assume that anti-H-Y1 response is not mediated by cytotoxic T cells (i.e., is not detectable by chromium release assay) and that we have been actually measuring the cytotoxicity against H-Y2. Anti°H-Y2 cytotoxicity might not be able to cause skin graft rejection on the basis of different concentrations of H-Y1 and H-Y2 antigens on lymphocytes and epidermal cells.
Kralova and Demant (20) have suggested that the H-2 complex also regulates the expression of the H-Y antigen, and the effect of these genes (mapping to the left of IC) may be different on thymus and skin cells. For example, in B10.A(SR) strain, the H-Y antigenicity would be strong on thymus cells but weak on skin cells. Their results show that these genes in the H-2 k haplotype determine a strong H-Y antigenicity on the skin, whereas the H-2 b haplotype is associated with low antigenicity. In our experiments, these factors seem to have no effect on skin graft rejection: (HTI x B10.A(2R))FI females rejected B10.A(2R) and HTI male skin at the same rate (Table HI) . To rule out the possibility that the lack of anti-H-Y cytotoxic response in strains capable of graft rejection (e.g. B10.A(5R)) was due to low H-Y antigenicity on lymphocytes (normal targets in the 5~Cr-release assay), we used syngenic male 5~Cr-labeled epidermal cells as targets, but these results were also negative (unpublished observations).
Whatever the rejection mechanism of syngeneic male graft is, it is evident that the H-Y antigen has some significance in clinical transplantations. It has been reported that female recipients of male kidney grafts survived longer than did female recipients of female grafts (21) . This might be attributed to anti-H-Y antibody enhancement. But there are other studies which show that the H-Y antigen is deleterious for graft survival. Goulmy et al. (22) found a patient with aplastic anemia who rejected a bone marrow graft from her HLA-identical brother, and her lymphocytes were cytotoxic to male cells, but restricted by an HLA product in a manner analogous to the mouse system.
Summary
The ability of female mice to rapidly reject syngeneic male skin grafts is largely determined by dominant genes in the IB region of the H-2 b haplotype, whereas the ability to produce anti-H-Y cytotoxic cells is determined by a dominant gene in the IA region of the H-2 b haplotype, or by complementary genes in the IC region of some other haplotypes. Thus, it seems that H-2-
